Nanosonics stock has an annual meeting on November 4, 2026

Published on 10/15/2026 at 20:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal year 2026 revenue reached AUD 203.90 million, up 2.70 percent year over year. Nanosonics stock costs EUR 1.73 on October 15, 2026.

Annual meeting and valuation

Nanosonics will hold its annual meeting on November 4, 2026.
Fiscal year 2026 revenue reached AUD 203.90 million, up 2.70 percent from fiscal year 2025.
Nanosonics stock costs EUR 1.73 at Lang & Schwarz on October 15, 2026 at 8:43 p.m. CEST.
Nanosonics trades at a P/E ratio of 48.53.

Nanosonics, AU000000NAN9, Illustration mit AI erstellt.

Nanosonics will hold its annual meeting on November 4, 2026, giving investors the next scheduled corporate date for the Australian medical technology company, according to Simply Wall St. Nanosonics stock was trading at EUR 1.73 at Lang & Schwarz on October 15, 2026 at 8:43 p.m. CEST.

Fiscal year revenue reached AUD 203.90 million

Nanosonics reported fiscal year 2026 revenue of AUD 203.90 million, up 2.70 percent from AUD 198.60 million in fiscal year 2025. Net income fell 14.00 percent to AUD 17.80 million, while net profit margin declined to 8.70 percent from 10.00 percent, according to Simply Wall St. The contrast is clear: revenue grew, but profit conversion weakened.

Stock remains near its yearly low

On the ASX, Nanosonics last stood at AUD 2.80 on October 15, 2026 at 4:10 p.m. AEDT, down 0.36 percent from AUD 2.81. Its 52-week range was AUD 2.64 to AUD 4.76, placing the latest Australian quotation AUD 0.16 above the low and AUD 1.96 below the high. The stock was down 39.00 percent over one year as of October 14, 2026.

Valuation and November date

The market capitalization was AUD 837.7 million and the trailing P/E ratio was 48.53 on October 15, 2026. Nanosonics operates in infection prevention, with its trophon systems and related consumables forming the core of its medical technology business. The annual meeting on November 4, 2026 is the next dated corporate event identified in the reviewed investor calendar.

Comparison with peers

Nanosonics: minus 0.36 percent, P/E 48.53, market capitalization AUD 837.7 million.

PolyNovo (ASX, AUD): minus 2.19 percent, P/E 85.24, market capitalization AUD 618.3 million.

Ansell (ASX, AUD): plus 0.24 percent, P/E 21.94, market capitalization AUD 6.4 billion.

Price and company profile

Nanosonics combines a EUR 1.73 Lang & Schwarz quotation with an ASX valuation of AUD 837.7 million and a trailing P/E ratio of 48.53. Its fiscal year 2026 revenue increased 2.70 percent, but net income and margin both declined, leaving the November 4, 2026 annual meeting as the next scheduled date.

Nanosonics stock was trading at EUR 1.73 at Lang & Schwarz on October 15, 2026 at 8:43 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Nanosonics stock.